FRESENIUS MEDICAL CARE AG (FME.DE) Stock Price, Forecast & Analysis
Europe - Frankfurt Stock Exchange - FRA:FME - DE0005785802 - Common Stock
FME.DE Key Statistics, Chart & Performance
The current stock price of FME.DE is 39.18 EUR. In the past month the price decreased by -3.19%. In the past year, price decreased by -11.12%.
FME.DE Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| FRE.DE | FRESENIUS SE & CO KGAA | 14.36 | 27.58B | ||
| HI.MI | HEALTH ITALIA SPA | 18.26 | 56.24M | ||
| EUK.MI | EUKEDOS SPA | N/A | 16.03M | ||
| V3V.DE | FAMICORD AG | N/A | 104.96M |
Related stock screener links
About FME.DE
Company Profile
Fresenius Medical Care AG engages in the provision of products and services for individuals with renal diseases. The company is headquartered in Bad Homburg Vor Der Hohe, Hessen and currently employs 109,916 full-time employees. The firm provides dialysis care and related services to persons suffering from end-stage renal disease (ESRD) and offers other extracorporeal therapies, as well as other healthcare services. The company has two operating segments such as care delivery segment which consolidates the global health care services business and care enablement segment includes research and development (R&D), manufacturing, supply chain, and commercial operations. The company develops and manufactures health care products, which includes dialysis and non-dialysis products. Such as hemodialysis machines, peritoneal cyclers, dialyzers, peritoneal solutions and granulates, bloodlines, renal pharmaceuticals, and systems for water treatment. Its non-dialysis products include acute cardiopulmonary and apheresis products. The company owns, operates, or manages dialysis clinics sells products to other dialysis providers.
Company Info
FRESENIUS MEDICAL CARE AG
Else-Kroener-Strasse 1
Bad Homburg vor der Hohe HESSEN DE
Employees: 111513
Phone: 4961726090
FRESENIUS MEDICAL CARE AG / FME.DE FAQ
What does FME do?
Fresenius Medical Care AG engages in the provision of products and services for individuals with renal diseases. The company is headquartered in Bad Homburg Vor Der Hohe, Hessen and currently employs 109,916 full-time employees. The firm provides dialysis care and related services to persons suffering from end-stage renal disease (ESRD) and offers other extracorporeal therapies, as well as other healthcare services. The company has two operating segments such as care delivery segment which consolidates the global health care services business and care enablement segment includes research and development (R&D), manufacturing, supply chain, and commercial operations. The company develops and manufactures health care products, which includes dialysis and non-dialysis products. Such as hemodialysis machines, peritoneal cyclers, dialyzers, peritoneal solutions and granulates, bloodlines, renal pharmaceuticals, and systems for water treatment. Its non-dialysis products include acute cardiopulmonary and apheresis products. The company owns, operates, or manages dialysis clinics sells products to other dialysis providers.
What is the current price of FME stock?
The current stock price of FME.DE is 39.18 EUR. The price decreased by -2.59% in the last trading session.
What is the dividend status of FRESENIUS MEDICAL CARE AG?
FRESENIUS MEDICAL CARE AG (FME.DE) has a dividend yield of 3.53%. The yearly dividend amount is currently 1.19.
What is the ChartMill rating of FRESENIUS MEDICAL CARE AG stock?
FME.DE has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 5 out of 10.
What is the GICS sector and industry of FME stock?
FRESENIUS MEDICAL CARE AG (FME.DE) operates in the Health Care sector and the Health Care Providers & Services industry.
When does FRESENIUS MEDICAL CARE AG (FME.DE) report earnings?
FRESENIUS MEDICAL CARE AG (FME.DE) will report earnings on 2026-02-24, after the market close.
FME.DE Technical Analysis
FME.DE Fundamental Analysis
ChartMill assigns a fundamental rating of 5 / 10 to FME.DE. FME.DE has only an average score on both its financial health and profitability.
FME.DE Financial Highlights
Over the last trailing twelve months FME.DE reported a non-GAAP Earnings per Share(EPS) of 3.76. The EPS increased by 16.77% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 3.66% | ||
| ROA | 2.33% | ||
| ROE | 5.55% | ||
| Debt/Equity | 0.73 |
FME.DE Forecast & Estimates
29 analysts have analysed FME.DE and the average price target is 47.6 EUR. This implies a price increase of 21.5% is expected in the next year compared to the current price of 39.18.
For the next year, analysts expect an EPS growth of 21.73% and a revenue growth 1.57% for FME.DE